Works by Lau, Sally C. M.

Results: 2
    1
    2

    Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 3, p. 1, doi. 10.1002/cncr.35738
    By:
    • Sands, Jacob M.;
    • Champiat, Stéphane;
    • Hummel, Horst‐Dieter;
    • Paulson, Kelly G.;
    • Borghaei, Hossein;
    • Alvarez, Jean Bustamante;
    • Carbone, David P.;
    • Carlisle, Jennifer W.;
    • Choudhury, Noura J.;
    • Clarke, Jeffrey M.;
    • Gadgeel, Shirish M.;
    • Izumi, Hiroki;
    • Navarro, Alejandro;
    • Lau, Sally C. M.;
    • Lammers, Philip E.;
    • Huang, Shuang;
    • Hamidi, Ali;
    • Mukherjee, Sujoy;
    • Owonikoko, Taofeek K.
    Publication type:
    Article